Coronary heart disease and type 2 diabetes;Maladie coronaire et diabete de type 2

Revue du Praticien

Volumn 49, Issue 1, 1999, Pages 34-39

  Passa, Philippe ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTERY DISEASE; CORONARY RISK; DIABETIC ANGIOPATHY; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; CAUSE OF DEATH; CORONARY ARTERY DISEASE; EXERCISE TEST; HEART MUSCLE REVASCULARIZATION; MORTALITY; RISK FACTOR;

CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; EXERCISE TEST; HUMANS; MYOCARDIAL REVASCULARIZATION; RISK FACTORS;

EID: 0032901403     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. For the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993 ; 16 : 434-44.
2. Fontbonne A, Eschwege E. Insulin resistance, hypertriglyceridemia and cardiovascular risk. The Paris Prospective Study. Diabete Metab 1991 ; 17 : 93-5.
3. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984 ; 310 : 356-60.
4. Mac Leod JM, Lutace J, Marshall SM Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995 ; 38 : 610-6.
5. Kannel WR, Mc Gee DL. Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 1979 ; 59 : 8-13.
6. Uusitupa MIJ, Niskasnen L, Siltonen O et al. Ten-year cardio-vascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 diabetic patients and non diabetic subjects. Diabetologia 1993 ; 36 : 1175-84.
7. Kuusisto J, Mykkänen L, Pyörälä k, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994 ; 43 : 960-7.
8. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 ; 37 : 1595-607.
9. Haffner SH, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes. JAMA 1990 ; 263 : 2893-8.
10. Passa Ph, Drouin P, Issa-sayegh M et al. Coronaires et Diabète. Recommandations de l'ALFEDIAM. Diabetes Metab 1995 ; 21 : 446-51.
11. Nesto R, Phillips R. Asymptomatic myocardial ischemia in diabetic patients.Am J Med 1986 ; 80 (suppl 4 C) : 40-7.
12. Paillole C, Passa Ph, Paycha F et al. Non-invasive identification of severe coronary artery disease in patients with long-standing diabetes mellitus. Eur J Med 1992 ; 1 : 464-8.
13. Koistinen MJ, Huikuri MV, Pirttiaho H, Linnaluoto MK, Takkunen JT. Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. Br Heart J 1990 ; 14 : 1642-4.
14. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa Ph. Detection of coronary artery disease in diabetic patients. Diabetologia 1995 ; 38 : 726-31.
15. Yusuf S, Zucker D, Pedruzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994 ; 344:563-9.
16. Barzilay JL, Kronmac RA, Bittner V et al. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > 65 years. Report from the Coronary Artery Surgery Study (CASS registry). Am J Cardiol 1994 ; 74 : 334-9.
17. Lawrie GM, Morris GC, Glaeser DH. Influence of diabetes mellitus on the results of coronary bypass surgery. JAMA 1986; 256 : 2967-71.
18. The Bypass Angioplasty Revascularisation Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
19. Passa Ph. Le traitement médical de la maladie coronaire chez les diabétiques. Diabétotogie et facteurs de risque. 1997 ; 18 : 145-50.
20. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 1992 ; 268 : 1292-300.
21. Kjeskhus J, Pedersen TR, for the Scandinavian Simvastatin Survival Study Group. Reducing the risk of coronary events, evidence from the Scandinavian Simvastatin Survival Study (4 S). Am J Cardiol 1995 ; 75 : 646-86.
22. Goldberg R. Diabetic response to pravastatin during the CARE study. Circulation 1996 ; 94 : 1339, abst 3159.
23. Soler NG, Pentcost BL, Barnett MA et al. Coronary care for myocardial infarction in diabetics. Lancet 1974 ; i : 475-7.
24. Oswald GA, Corcorani S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984 ; i : 1264-7.
25. Genes N, Vaur L, Dubroca I, Etienne S, Cambou JP, Danchin N. Pronostic de l'infarctus du myocarde chez le patient diabétique : résultats de l'étude épidémiologique USIK. Presse Med 1998 ; 27 : 1003-8.
26. ISIS-2 Collaboration Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17.187 cases of suspected acute myocardial infarction. Lancet 1988 ; 2 : 349-60.
27. Kjeskus J, Gilpin E, Blackey A, Henning H, Ross J. Diabetic patients and betablockers after acute myocardial infarction. Eur Heart J 1990 ; 11 : 43-50.
28. Zuanetti G, Latini R, Maggioni AP et al for the GISSI-3 Investigators. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction. Circulation 1997 ; 96 : 4239-45.
29. Malmberg K, Ryden L, Effendic S et al. On behalf of the DIGAMI Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study), effects on mortality at 1 year. J Am Coll Cardiol 1995 ; 26 : 57-65.
30. Euroaspire Study Group. EUROASPIRE. A European society of cardiology survey of secondary prevention of coronary prevention of coronary heart disease; Principal results; Eur Heart J 1997 ; 18 : 1569-82;